Mukka Proteins (MUKKA) | Financial Analysis & Statements
Mukka Proteins Ltd. Small-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.6B
Gross Profit
355.6M
21.56%
Operating Income
112.9M
6.85%
Net Income
15.9M
0.96%
EPS (Diluted)
₹0.05
Balance Sheet Metrics
Total Assets
12.4B
Total Liabilities
7.8B
Shareholders Equity
4.6B
Debt to Equity
1.68
Cash Flow Metrics
Operating Cash Flow
539.0M
Free Cash Flow
28.8M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Mukka Proteins Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 9.8B | 13.4B | 11.6B | 7.7B | 5.9B |
| Cost of Goods Sold | 8.0B | 11.7B | 9.9B | 6.6B | 5.2B |
| Gross Profit | 1.8B | 1.7B | 1.7B | 1.1B | 669.0M |
| Gross Margin % | 18.4% | 12.9% | 14.8% | 14.1% | 11.3% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 771.3M | 736.5M | 729.2M | 429.1M | 413.0M |
| Other Operating Expenses | 13.3M | 12.1M | 16.0M | 12.5M | 6.9M |
| Total Operating Expenses | 784.6M | 748.6M | 745.2M | 441.5M | 419.9M |
| Operating Income | 815.7M | 932.8M | 803.6M | 395.9M | 139.1M |
| Operating Margin % | 8.3% | 7.0% | 6.9% | 5.2% | 2.4% |
| Non-Operating Items | |||||
| Interest Income | 37.3M | 31.7M | 16.8M | 13.1M | 9.1M |
| Interest Expense | 266.2M | 189.9M | 116.2M | 75.6M | 73.3M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 602.7M | 874.6M | 659.4M | 359.8M | 154.6M |
| Income Tax | 121.7M | 131.5M | 184.2M | 101.6M | 44.4M |
| Effective Tax Rate % | 20.2% | 15.0% | 27.9% | 28.2% | 28.8% |
| Net Income | 481.0M | 743.0M | 475.2M | 258.2M | 110.1M |
| Net Margin % | 4.9% | 5.5% | 4.1% | 3.4% | 1.9% |
| Key Metrics | |||||
| EBITDA | 1.0B | 1.2B | 893.6M | 518.4M | 305.5M |
| EPS (Basic) | ₹1.55 | ₹3.10 | ₹1.47 | ₹0.81 | ₹0.30 |
| EPS (Diluted) | ₹1.55 | ₹3.10 | ₹1.47 | ₹0.81 | ₹0.30 |
| Basic Shares Outstanding | 300000000 | 225683060 | 300000000 | 300000000 | 300000000 |
| Diluted Shares Outstanding | 300000000 | 225683060 | 300000000 | 300000000 | 300000000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Mukka Proteins Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 30.8M | 944.4M | 265.5M | 115.4M | 31.5M |
| Short-term Investments | 584.8M | 442.5M | 139.6M | 65.1M | 93.6M |
| Accounts Receivable | 2.0B | 1.9B | 1.1B | 613.3M | 478.9M |
| Inventory | 5.6B | 4.2B | 2.3B | 1.6B | 1.5B |
| Other Current Assets | -10.0K | 10.0K | -30.0K | -20.0K | 10.0K |
| Total Current Assets | 9.3B | 8.2B | 4.6B | 2.9B | 2.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 452.0M | 394.0M | 349.4M | 18.9M | 0 |
| Goodwill | 135.7M | 820.0K | 460.0K | 120.0K | 260.0K |
| Intangible Assets | 690.0K | 820.0K | 460.0K | 120.0K | 260.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -10.0K | 30.2M | 10.0K | -20.0K | -990.0K |
| Total Non-Current Assets | 1.5B | 1.2B | 1.1B | 1.1B | 974.2M |
| Total Assets | 10.8B | 9.4B | 5.8B | 3.9B | 3.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.4B | 1.4B | 1.3B | 975.5M | 1.0B |
| Short-term Debt | 4.5B | 3.6B | 2.5B | 1.7B | 1.5B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 320.0K | 10.0K | 4.3M | 3.6M | 5.5M |
| Total Current Liabilities | 6.1B | 5.2B | 4.0B | 2.8B | 2.7B |
| Non-Current Liabilities | |||||
| Long-term Debt | 41.4M | 68.8M | 106.8M | 80.6M | 140.7M |
| Deferred Tax Liabilities | 25.3M | 24.2M | 38.4M | 31.7M | 27.3M |
| Other Non-Current Liabilities | 10.0K | 10.0K | -10.0K | 10.0K | 5.4M |
| Total Non-Current Liabilities | 94.1M | 115.6M | 165.2M | 128.1M | 177.4M |
| Total Liabilities | 6.2B | 5.3B | 4.2B | 2.9B | 2.8B |
| Equity | |||||
| Common Stock | 300.0M | 300.0M | 220.0M | 220.0M | 55.0M |
| Retained Earnings | 2.3B | 1.8B | 1.1B | 685.1M | 608.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.6B | 4.1B | 1.6B | 1.0B | 690.6M |
| Key Metrics | |||||
| Total Debt | 4.5B | 3.7B | 2.6B | 1.8B | 1.6B |
| Working Capital | 3.2B | 3.0B | 612.4M | 99.7M | -106.2M |
Balance Sheet Composition
Mukka Proteins Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 602.7M | 874.6M | 659.4M | 359.8M | 154.6M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -2.1B | -2.4B | -1.6B | -347.9M | -336.6M |
| Operating Cash Flow | -1.3B | -1.4B | -877.4M | 56.4M | -128.3M |
| Investing Activities | |||||
| Capital Expenditures | -184.4M | -149.9M | -80.1M | -62.8M | -102.3M |
| Acquisitions | - | 31.1M | 33.9M | 10.1M | 38.2M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -168.3M | -79.9M | -10.6M | -39.2M | -23.3M |
| Financing Activities | |||||
| Share Repurchases | -25.3M | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 872.4M | 2.8B | 909.8M | 309.0M | 98.1M |
| Free Cash Flow | -1.4B | -1.7B | -645.4M | -17.0M | -47.3M |
| Net Change in Cash | -572.1M | 1.4B | 21.7M | 326.2M | -53.5M |
Cash Flow Trend
Mukka Proteins Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.95
Price to Book
1.58
Price to Sales
0.50
PEG Ratio
-1.56
Profitability Ratios
Profit Margin
3.11%
Operating Margin
6.34%
Return on Equity
10.18%
Return on Assets
4.32%
Financial Health
Current Ratio
1.38
Debt to Equity
131.93
Beta
0.17
Per Share Data
EPS (TTM)
₹1.50
Book Value per Share
₹15.12
Revenue per Share
₹48.18
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MUKKA | 7.2B | 15.95 | 1.58 | 10.18% | 3.11% | 131.93 |
| Nestle India | 2.7T | 76.65 | 60.70 | 76.34% | 15.11% | 8.61 |
| Britannia Industries | 1.4T | 57.14 | 36.97 | 49.73% | 12.84% | 58.42 |
| BN Holdings | 38.6B | 26.71 | 5.01 | 5.05% | 8.31% | 21.23 |
| Cian Agro Industries | 35.7B | 31.81 | 1.76 | 2.04% | 8.08% | 62.05 |
| Gopal Snacks | 34.5B | 839.85 | 7.97 | 4.69% | 0.30% | 14.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.




